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Ectromelia virus (ECTV), the causative agent of mousepox, expresses an extracellular interferon-g binding protein (IFN-gBP) with
homology to the ligand binding domains of the IFN-g high affinity receptor (IFN-gR1). Unlike the cellular receptor, the IFN-gBP binds
IFN-g from several species. The IFN-gBP is synthesized early after infection, accumulating in the extracellular milieu as dimers composed
of two protein species with Mr of 34.6 or 33.0 kDa. Homodimers are covalently linked by an interchain disulphide bond at position 216.
The IFN-gBP has complex N-linked oligosaccharides at positions 41 and 149 as determined by site-directed mutagenesis and glycosidase
treatment. Glycosylation at position 41 is required for secretion from mammalian cells and may play a role in the activity of the IFN-gBP.
Glycosylation at position 149 is not required for secretion, and the lack of glycosylation at this site does not diminish ligand binding as
measured by surface plasmon resonance (SPR) and ELISA.
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Poxviruses are large, double-stranded DNA viruses that
replicate within the cytoplasm of infected cells. Approx-
imately 25% of the 200 open reading frames (ORFs) present
in the prototypic orthopoxvirus vaccinia (VACV) are
bnonessentialQ for virus replication in cell culture. Some of
the ORFs have been demonstrated to modulate host
responses during the virus life cycle and others are thought
to have this property (Buller and Palumbo, 1991; Perkus
et al., 1991). Most genes encoding these host response
modifiers (HRMs) are located in the terminal regions of the
genome and show considerable variability among the
poxvirus species in function (active or inactive) and
specificity (narrow or broad range interactions with related
host proteins). Host pathways affected include cell macro-
molecular synthetic processes, apoptotic mechanisms, and0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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orthopoxviruses encode at least four distinct TNF-binding
proteins as well as binding proteins (BP) for chemokines,
IL-18, IL-1h and IFNs (Alcami and Smith, 2002). These
proteins are secretory homologs of cellular receptors and
cytokine binding proteins, which block cytokine action
extracellularly prior to receptor engagement.
The IFN-gBP is found in a range of poxviruses and is
probably the best studied of the cytokine binding proteins.
The various poxvirus IFN-gBPs have been shown to have
high affinity for IFN-g as demonstrated by IFN-g binding
assays, and the inhibition of IFN-g action in functional
assays (Alcami and Smith, 1995, 1996; Mossman et al.,
1995a, 1995b, 1996; Upton et al., 1992). One of the most
interesting properties of the IFN-gBPs is the ability of
certain poxvirus orthologs to bind IFN-g from a broad array
of host species, whereas human and murine IFN-g are
known to bind their receptor in a species-specific manner. In
one study, vaccinia, cowpox, and camelpox viruses’ IFN-
gBPs were shown to inhibit the biological activity of005) 41–50
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(Alcami and Smith, 1995). In a second study, the IFN-gBP
from ECTV was shown to bind human, murine, and rabbit
IFN-g, suggesting that it had one of the broadest reactivities
of any of the poxvirus IFN-gBPs (Mossman et al., 1995a).
Since the ECTV IFN-gBP is structurally related to the
cellular IFN-gR1, understanding the molecular basis for its
ability to bind IFN-g from multiply species may provide
insights into the stringent binding specificity of the cellular
receptor. As a first step in a structure/function character-
ization of the ECTV IFN-gBP, we have defined its co-
translational and post-translational modifications as well as
the importance of these modifications on secretion and
activity.Results
Ectromelia virus IFN-cBP is an early protein
The presence of an early promoter (AAAAATTTAAAA-
TATATTA) and a transcription termination (TTTTTAT)
signal proximal to the IFN-gBP gene is consistent with
early expression during infection (Moss et al., 1991;
Mossman et al., 1995a). To test this prediction, ECTV-
infected BS-C-1 cell cultures were labeled for 15 min with
[35S]-L-Met/Cys at indicated times post-infection (p.i.), and
cell lysates were assayed for IFN-gBP by immunoprecipi-
tation reactions. Fig. 1 demonstrates that IFN-gBP migrated
in reducing SDS-PAGE as a sharp band with a Mr ~33 kDa
(inset), which was 4.3 kDa greater than the 28.7 kDa
predicted for the IFN-gBP lacking a signal peptide. Protein
expression could be detected as early as 1 h p.i., peaked at 4
h p.i. followed by a dramatic decrease in synthesis after 8 h
p.i. Western blot analyses detected IFN-gBP withMr of 34.6Fig. 1. Synthesis of IFN-gBP peaks at 4-h post infection. BS-C-1 cells were infecte
[35S]-L-Met/Cys for 15 min, washed and harvested immediately into SDS-PAG
polyclonal rabbit sera, and analyzed by 12% SDS-PAGE followed by phosp
ImageQuaNT software and plotted as relative units versus h.p.i. IFN-gBP is idenkDa and 33 kDa in ECTV infected BS-C-1 cell culture
supernatants by 2 h p.i, but not in uninfected BS-C-1 cells or
BS-C-1 cells infected with an ECTV mutant lacking an
intact IFN-gBP gene (data not shown). These results
indicated that IFN-gBP is an early viral protein and
undergoes post-translational modification prior to secretion.
Synthesis, modification and secretion of the IFN-cBP
As a first step in characterizing the post-translational
modifications of the IFN-gBP, the time course of IFN-gBP
synthesis was determined (Fig. 2, panel A). Immediately
after a 15 min pulse with [35S] L-Met/Cys, IFN-gBP from
cell lysate migrated as a single species with a Mr of 33 kDa.
Analyses of the products by non-reducing SDS-PAGE
indicated that it was a disulfide-bonded dimer through
cysteine 216 (Fig. 2, panel B). Within 15 min of chase, 80%
of the intracellular IFN-gBP was degraded, while the
remaining 20% was secreted into the medium with a t1/2
of 90 min. IFN-gBP (Mr ~ 34.6 kDa) was not detected in the
culture supernatant until 1 h after the initiation of the chase
period. The decrease in intracellular IFN-gBP over time can
be accounted for by its appearance in the culture super-
natant, excluding the decrease in cell-associated radio-
activity between 0 and 0.5 h of chase. The increase in the
Mr of IFN-gBP on secretion from infected cells was
consistent with the replacement of a high mannose
carbohydrate moiety with a complex carbohydrate in the
Golgi. This was tested by digestion of IFN-gBP from cell
lysate and culture supernatant with the Endo H, a
glycosidase that cleaves high mannose structures from
N-linked glycoproteins (Fig. 2, panel C). This experiment
shows that IFN-gBP in all of the cell lysate samples can be
converted into a faster migrating species following digestion
with Endo H. The Mr ~ 30 kDa size of the Endo H digestiond with ECTVand at the indicated times p.i., infected cells were labeled with
E loading buffer. IFN-gBP was immunoprecipitated with anti-IFN-gBP
hor screen autoradiography. The amount of protein was quantitated by
tified with an arrowhead and the apparent molecular mass is indicated.
Fig. 2. Synthesis, modification and secretion of IFN-gBP in BS-C-1 cells. (Panel A) Time course of IFN-gBP secretion. BS-C-1 cells were infected with
20 pfu/cell ECTV and labeled at 4 h p.i. with 100 ACi/ml [35S]-L-Met/Cys. IFN-gBP in NP-40 soluble cell lysate (inset, upper panel) and cell supernatant
(inset, lower panel) was isolated at the indicated times, immunoprecipitated with anti-IFN-gBP polyclonal rabbit sera, and analyzed by 12% SDS-PAGE
followed by phosphor screen autoradiography. Radioactivity was quantitated using ImageQuaNT software and plotted as relative units versus h. post-chasing.
The apparent molecular masses of IFN-gBP are indicated. (Panel B) Culture supernatants from WT and C216A IFN-gBP transfections were analyzed by 12%
SDS-PAGE with, and without, the presence of h-mercaptoethanol (2-ME) followed by Western blot analysis. Molecular weight markers are given. (Panel C)
Endo H sensitivity of IFN-gBP. Aliquots of samples described in panel A were digested with Endo H, immunoprecipitated and analyzed by 12% SDS-PAGE
followed by phosphor screen autoradiography. (Panel D) Extracellular IFN-gBP contains complex N-linked carbohydrates. Purified, secreted IFN-gBP was
subjected to either Endo H or N-glycosidase F digestions and was analyzed in 12% SDS-PAGE followed by Western blot analysis. The apparent molecular
masses are indicated.
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predicted from the gene structure, and this discrepancy
may be due to the residual N-linked N-acetylglucosamine
residue on the Endo H-digested IFN-gBP. In contrast, the
majority of the IFN-gBP in the culture supernatant is
resistant to Endo H digestion. A similar analysis was carried
out with non-radiolabeled purified extracellular IFN-gBP
and a second glycosidase, N-glycosidase F, which only
cleaves N-linked carbohydrate moieties from asparagine
residues (Fig. 2, panel D). The untreated IFN-gBP migratedas a broad band, which on further analysis, was composed
of species with Mr~ 34.6 and 33 kDa. In contrast, the
N-glycosidase F digestion product migrated with a Mr~28.7
kDa, which is consistent with the predicted MW of the
primary gene product minus the signal peptide. Endo H
digestion yields a complex mixture of both Endo H-
sensitive and -resistant species indicating the secreted
IFN-gBP contains a mixture of both high mannose and
complex N-linked sugars. Since the mature IFN-gBP is
predicted to have two N-linked carbohydrate moieties, the
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glycans, both of which would be resistant to Endo H
digestion. Similarly, the Endo H-sensitive bands could
contain multiple species with a mixture of complex and
high-mannose or hybrid-type glycans. The Mr of the fastest
migrating product from the completed N-glycosidase F and
Endo H digestions were not identical, because N-glyco-
sidase F cleaves between the innermost GlcNAc and the
asparagine residue, whereas Endo H leaves a GlcNAc
moiety on the polypeptide. Although the N-glycosidase F
digestion of IFN-gBP suggested that the protein contained
only N-linked glycans, we further tested the purified IFN-
gBP for the presence of O-linked glycans. The IFN-gBP
was found to be resistant to O-glycanase under conditions
where a positive control (feutin) was shown to be sensitive
to digestion (data not shown). To eliminate the possibility
that the bulky N-glycans masked the O-glycans from
digestion, the purified IFN-gBP was digested concomitantly
with N-glycosidase F and O-glycanase. The resulting IFN-
gBP band remained in the same location as that yielded by
N-glycosidase F digestion alone (data not shown). This
suggested that under the conditions employed, there
appeared to be no O-linked glycans on the IFN-gBP.
Additionally, IFN-gBP digested with sialidase showed that
sialic residues are present on the 34.6 kDa protein, and
competitive ELISA indicated they are not necessary for
function (data not shown). Taken together, these results
indicate that the IFN-gBP exists as a dimer with two N-
linked carbohydrate moieties, with the intracellular protein
having a high mannose core, while the major secreted form
has had the mannose core replaced by a complex glycan.
IFN-cBP secretion is blocked by tunicamycin
To determine if glycosylation is required for IFN-gBP
secretion, we inhibited the formation of N-glycans on the
newly synthesized polypeptides through the addition of
tunicamycin to infected cell cultures (Struck et al., 1978).
The ECTV IFN-gBP was expressed from pTM1 in BS-C-1
cells under the control of a T7 promoter from a VACV
recombinant (lacking the endogenous ortholog) in the
presence or absence of tunicamycin. The delay in theFig. 3. IFN-gBP secretion is blocked by tunicamycin. Culture lysates (upper pane
the presence (+) or absence () of tunicamycin (Tun, 0.5 Ag/ml) were harvested at
PAGE followed by Western blot analysis.appearance of the IFN-gBP expressed from the T7 promoter
(Fig. 3) versus the natural infection (Fig. 1) may be due to
the choice of the vaccinia virus promoter (7.5 K) regulating
expression of the T7 polymerase. SDS-PAGE and Western
blot analysis of culture lysates from infected cells in the
presence of tunicamycin detected an intracellular, but not a
secreted form of the IFN-gBP. The intracellular IFN-gBP
migrated with Mr of 28.7 kDa, which was consistent with
the size of the predicted IFN-gBP gene product and
Escherichia coli expressed protein lacking the signal
sequence (data not shown). Expression of the IFN-gBP by
the VACV-T7 system yielded a protein, which migrates with
aMr indistinguishable from the natural infection. The failure
to detect secreted IFN-gBP from the infected cells treated
with tunicamycin indicated a role of N-linked glycosylation
in the folding and/or secretion process.
N-Linked glycosylation at position 41 is required for
IFN-cBP secretion and activity
Computer-assisted analysis of the predicted protein
sequence of the IFN-gBP suggests that the protein has
two potential N-linked glycosylation sites at residue 41 and
149. Tunicamycin treatment indicated that N-linked glyco-
sylation was important for secretion of IFN-gBP, but did not
indicate how many of the predicted N-linked glycosylation
sites were utilized. To investigate this issue, we chose in situ
mutagenesis to alter the third residue of each N-linked
glycosylation consensus sequences in the ifn-cbp gene in
pTM1 as follows: S43A, T151A and S43A/T151A. Cultures
transfected with plasmids containing T151A mutant and
wild type (WT) ifn-cbp genes synthesized similar quantities
of IFN-gBP, although more of the WT than T151A mutant
protein was found in the culture supernatant (Fig. 4, panel
A). With the S43A and S43A/T151A plasmid transfection,
there was a complete absence of secreted protein, and the
protein levels in the lysates were reduced when compared to
T151A plasmid transfected cultures. Despite the lack of
secretion, both the proteins were stable in the cells (data not
shown).
To determine whether glycosylation of IFN-gBP is
required for activity, WT and glycosylation site mutantsl) and supernatants (lower panel) from VACV-t7 infected BSC-1 cultures in
different times p.i. as described above. Samples were analyzed by 12% SDS-
Fig. 4. N-linked glycosylation at position 41 is required for IFN-gBP secretion and activity. (Panel A) N-linked glycosylation at position 41 is essential for
IFN-gBP secretion. Site-specific mutagenesis was used to mutate singly and together serine 43 (S43A) and threonine 151 (T151A) in pTM1-ifn-cbp+. Mutant
and WT constructs and control plasmid were transfected into VACV-t7 infected CV-1 cells. NP-40-soluble cell lysates (upper panel) and cell supernatant
(lower panel) were analyzed by 12% SDS-PAGE followed by Western blot. The loading volume of the WT cell lysate in the upper panel was 1/2 volume
loaded in all other lanes. The apparent molecular masses of IFN-gBP are indicated. (Panel B) N-linked glycosylation at position 41 is important for proper
protein folding. Wild type and N-linked glycosylation mutant lysates and supernatants from the experiment described in panel A were solubilized in loading
buffer in the presence or absence of 2-ME and analyzed by 12% SDS-PAGE followed by Western blot.
Table 1
Summary of SPR studies on IFN-gBP interaction with murine IFN-g
KD (nM) ka (M1 s1) (105) kd (s1) (105)
WT 0.42 F 0.18 1.39 F 0.39 5.76 F 3.09
T151A 0.36 F 0.21 1.68 F 0.90 5.85 F 5.07
C216A 0.60 F 0.16 0.97 F 0.34 6.11 F 3.31
Murine IFN-g was directly coupled to the surface of a CM5 sensor chip
and IFN-gBP and variants were injected at concentrations from 100 nM
to 0.1 nM. All combinations were tested at least three times, using
multiple murine IFN-g surfaces. Data were analyzed using BIAevaluation
3.2 and binding curves were fitted using the 1:1 binding model.
H. Bai et al. / Virology 334 (2005) 41–50 45of IFN-gBP were tested in a competitive ELISA and by
SPR for their ability to bind murine IFN-g. The S43A and
S43A/T151A proteins obtained from cell lysates had no
detectable murine IFN-g binding activity by ELISA or SPR
(data not shown). It is unclear whether glycosylation at
position 41 is required for IFN-g binding activity or if lack
of glycosylation at this site results in misfolding and a
secondary loss of function. To further address this issue,
secreted WT IFN-gBP was treated with N-glycosidase F
and assayed for activity by SPR. N-glycosidase F treatment
removed carbohydrate from ~50% of the IFN-gBP, as seen
by SDS-PAGE, and correlated with a reduction of ~60% of
the SPR response for murine IFN-g as seen for mock
digested protein. This suggests a role for carbohydrate in
murine IFN-g binding. Interestingly, insect cell expressed
IFN-gBP (Drosophila Expression System, Invitrogen Cor-
poration, Carlsbad, CA) with or without glycosylation at
positions 41 or 149 showed similar affinities and kinetics
for murine IFN-g by SPR (data not shown). We are unable
to reconcile the findings of these two experiments at this
time.To further test the effects of glycosylation at position 151
on activity of the IFN-gBP, secreted fractions of both the
T151A and WT IFN-gBP were analyzed by SPR, a more
robust assay technology. Both WT and the T151A mutant
showed comparable sub-nanomolar affinity for murine IFN-g
(Table 1). These data indicate that glycosylation of IFN-gBP
at position 41 is required for binding activity and secretion
from transfected cells, while glycosylation at position 151
does not appear necessary for function.
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To determine whether the S43A and S43A/T151A
proteins were assembled into multimeric forms, which is
an early event in the secretion of IFN-gBP, lysates
previously analyzed in binding assay were analyzed by
12% SDS-PAGE in the presence or absence of 2-ME
followed by Western blot. Based on Mr, WT and mutant
T151A proteins from the cellular lysate migrated as
monomers, dimers and trimers (Fig. 4, panel B). Interest-
ingly, the supernatant WT and mutant T151A proteins were
greater than 98% dimers. In contrast, the lysate S43A and
S43A/T151A mutant proteins appeared to form high MW
disulphide-linked aggregates as they could not be detected
by SDS-PAGE except in the presence of 2-ME (Fig. 4, panel
C). To further elucidate the role of dimerization in the
expression and secretion of the IFN-gBP, the mutant C216A
was analyzed under both reducing and non-reducing SDS-
PAGE. Under either condition, C216A was present as a
monomer, while the WT protein appeared to form a
disulphide linked dimer using C216 (Fig. 2, panel B). The
C216A protein was expressed and secreted at similar levels
to the WT protein; however, under non-reducing conditions
(lane 4), the band intensity for C216A is decreased. We
suspect this reduction in intensity may reflect aggregation of
the C216A mutant in the presence of SDS without a
reducing agent. To test the importance of disulphide linked
dimerization on activity of the IFN-gBP, C216A was
analyzed by SPR for binding to murine IFN-g (Table 1).
IFN-gBP with the C216A mutation demonstrated affinity
comparable to WT IFN-gBP, despite not existing as a
disulphide linked dimer. It is still unclear, however if the
IFN-gBP also exists in solution as a dimer independent of
the interchain disulphide bond at position C216.Discussion
The cytokine IFN-g has an important role in the response
to microbial infections (Farrar and Schreiber, 1993; Langer
and Pestka, 1988; Trinchieri and Perussia, 2004). Mice
lacking a functional IFN-g signaling pathway, through
either depletion of IFN-g by antibody treatment or genetic
manipulation, exhibit more severe disease following infec-
tion with VACVor ECTV (Harris et al., 1995; Huang et al.,
1993; Karupiah et al., 1993; Melkova and Esteban, 1994).
The genomes of most poxviruses encode secreted IFN-gBPs
that have sequence similarity to the extracellular domain of
the IFN-gR1. Infection with myxoma or vaccinia viruses
lacking IFN-gBP have shown IFN-gBP to be important in
virulence in a rabbit model of infection (Mossman et al.,
1996; Sroller et al., 2001). Attenuation of a VACV KO
mutant in a rabbit model of infection would not be
unexpected given that VACV IFN-gBP (B8R) has been
shown to bind rabbit IFN-g with high affinity, likewise thefailure of VACV IFN-gBP to inhibit the actions of murine
IFN-g would support no role in virulence in mouse models,
although this remains controversial (Alcami and Smith,
1995; Mossman et al., 1995a; Symons et al., 2002; Verardi
et al., 2001). The IFN-gBP from ECTV virus binds human,
rabbit and murine IFN-g with high affinity, and neutralizes
the antiviral activities of murine IFN-g, however, studies on
its biosynthesis and importance in a mouse model of
infection have not been published.
As predicted from nucleotide sequence analysis of its
promoter, and like the myxoma virus homolog (Mossman et
al., 1995b), the ifn-cbp gene is expressed early in the
replication cycle. Peak synthesis of the protein is observed
at 4-h post-infection. A dramatic disappearance of radio-
actively labeled intracellular IFN-gBP between 0 and 0.5 h
of chase was evident, and appeared due to degradation as
there was little IFN-gBP detected in either the culture
supernatant or NP-40 insoluble pellet at 0.5 h (data not
shown). A short half-life is a typical feature of many viral
and cellular proteins that have transcriptional regulatory
functions, such as the Tax protein of human T-cell leukemia
virus type 1 (Slamon et al., 1985), the E1A protein of
adenovirus (Spindler and Berk, 1984), and the c-Myc
protein (Yeilding et al., 1996); however, IFN-gBP is a
secreted immunomodulator with no known role in the
regulation of viral transcription. An alternative possibility is
that during the high m.o.i. (20 pfu/cell) conditions used in
this study, the folding machinery of the ER is overloaded by
viral glycoproteins in general, or IFN-gBP in particular.
This may result in viral protein that fails to fold properly. It
is now well established that misfolded proteins are removed
from the early secretory pathway and degraded by the
proteosome (Kouchi et al., 1998; Kowalski et al., 1998;
Parodi, 1999).
In non-reducing SDS-PAGE, IFN-gBP from cellular
lysates migrated as monomers, dimers and trimers,
whereas migration was almost uniformly as a dimer when
isolated from cell culture supernatants. Mutagenesis of the
C-terminal most cysteine (C216) revealed that covalent
dimerization occurs at this position, however the C216A
mutant protein was still effectively secreted into cell
culture supernatants and there was little alteration of
activity by SPR as compared to WT secreted protein.
Others also have observed that the secreted form of the
IFN-gBP exists as a higher ordered structure. In myxoma
virus, sedimentation equilibration analysis found the
extracellular form of IFN-gBP to behave as a trimer in
solution (Lalani et al., 1997). The extracellular IFN-gBPs
of vaccinia, cowpox and camelpox viruses were also
detected as a dimer (Alcami and Smith, 2002).
Newly synthesized IFN-gBP migrated in reducing SDS-
PAGE with a Mr of 33 kDa, 4.3 kDa greater than the 28.7-
kDa predicted for the IFN-gBP lacking the signal peptide.
Protein sequence analysis identified two potential N-linked
glycosylation sites in the mature protein, and in situ
mutagenesis confirmed that the sites at amino acid residue
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position 41 was required for secretion and function of IFN-
gBP, whereas as glycosylation at position 149 was not
required for secretion or binding to murine IFN-g. Western
blot analysis of Endo H digested, pulse labeled IFN-gBP,
and Endo H and N-glycosidase F digested purified secreted
IFN-gBP, also supported the use of two glycosylation sites
during IFN-gBP biosynthesis. The requirement of N-
glycosylation in secretion and function was also confirmed
by experiments with tunicamycin, an inhibitor of N-
glycosylation. A similar inhibition of secretion of glyco-
proteins in the presence of tunicamycin has been reported
for human plasma cholesteryl ester transfer protein and its
related phospholipid transfer protein (Au-Young and Field-
ing, 1992; Huuskonen et al., 1998; Swenson et al., 1987).
Also, the secretion of myxoma virus serine-proteinase
inhibitor was inhibited by mutating the N-glycosylation
sites (Nash et al., 2000).
The N-glycosylation site Asn41 appears important for
the IFN-gBP folding and dimerization. In the absence of a
reducing agent, the IFN-gBP monomer of mutant S43A
and S43A/T151A were difficult to detect consistent with
aggregation of IFN-gBP containing the S43A mutation.
This finding is in agreement with a number of studies that
found N-linked oligosaccharides are important in the
folding of glycoproteins and their interaction with molec-
ular chaperones, such as calnexin (Abouakil et al., 1993;
Bergeron et al., 1994; Helenius and Aebi, 2001; Riederer
and Hinnen, 1991; Werr and Prange, 2004; Zhang and
Dahms, 1993). For example, the interaction between
vesicular stomatitis virus G protein and calnexin is
necessary for proper folding and is prevented by removal
of carbohydrates or by inhibition of the endoplasmic
reticulum glycosidases (Hammond and Helenius, 1994).
Calnexin appears to bind to a broad range of glycoproteins
and anchors the polypeptides to the ER until they have
achieved their correct folding conformation. The results
presented here agree with the general finding that N-
glycans can play an important role in the ER secretory
pathway.
Analysis of ECTV IFN-gBP, the secreted glycosylation
variant T151A and the dimerization variant C216A by SPR
and ELISA revealed that neither change had a significant
effect on the affinity of ECTV IFN-gBP for binding tomurine
IFNg. Similar SPR studies have also been conducted with the
VACV IFN-gBP (Symons et al., 2002). They reported
affinities (KD) of the VACV IFN-gBP of 9  1011 M and
4 108 M for human and murine IFN-g, respectively. Here
we report a comparable KD of ECTV IFN-gBP for murine
IFN-g of ~4.2  1010 M. Interestingly, the reported rate
constants for VACV IFN-gBP interacting with human IFN-g
appear to reflect both a faster association rate (35-fold) and
faster dissociation rate (7.5-fold) than the current values for
ECTV IFN-gBP interaction with murine IFN-g. It is unclear
whether these results are due to a difference in affinities for
respective ligands, or the use of Fc tagged IFN-gBP forimmobilization versus a direct coupling of the ligand to the
sensor chip surface as employed in this study.Materials and methods
Materials
[35S]-l-methionine/cysteine ([35S]-L-Met/Cys) (N1000
Ci/mmol) was purchased from NEN Life Science Prod-
ucts, Inc. (Boston, MA). Protein G-Agarose was obtained
from Roche Diagnostics Corporation (Indianapolis, IN).
O-Glycanase [which cleaves Gal(h1-3)GalNAc(a1)-pNP],
N-Glycanase (peptide-N-glycosidase F) and Sialidase II
(which cleaves N-acetylneuraminic acid-pNP) were from
GLYKOTM, Inc. (Novato, CA). Tunicamycin was supplied
from Roche (Indianapolis, IN).
Cells and viruses
BS-C-1 and CV-1 cells (African monkey kidney cell
lines) were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM), containing 50 unit/ml penicillin, 50 Ag/
ml streptomycin, 2 mM l-glutamine and 10% FetalClone II
(HyClone Laboratories, Inc., Logan, UT).
The Moscow strain of ECTV was a second or third
passage of Mos-3-P1 (Chen et al., 1992). The WR strain of
VACV and a derivative virus expressing the T7 RNA
polymerase was kindly provided by Dr. Bernard Moss
(Fuerst et al., 1987). Virus stocks were prepared in BS-C-1
and stored at 70 8C until use. Virus infectivity was
measured on BS-C-1 monolayers (Chen et al., 1992).
Generation of deletion and recombinant viruses
The VACV-t7,B8R (hereafter VACV-t7) virus was
constructed through deletion of the B8R ORF (ifn-cbp)
in VACV-t7 virus by transient dominant selection using as a
selection marker the E. coli guanine phosphoribosyltrans-
ferase (gpt) (Falkner and Moss, 1988). AVACV-B8R virus
was constructed from VACV-WR by a similar approach.
Recombinant VACV-B8R,ectvifn-gbp+ (VACV-ifn-gbp+)
virus was constructed by infection of a culture of CV-1 cells
with VACV-B8R virus, which was subsequently trans-
fected with pTM1-ectvifn-cbp+. This plasmid contained
VACV tk gene flanking regions on either side of the ifn-cbp
gene, which was under control of T7 promoter (Fuerst et al.,
1987). Viruses were plaque purified three times and
pedigree was verified by PCR.
Plasmids
The ECTV ifn-cbp gene was cloned downstream of the
T7 promoter of the pTM1 vector (Fuerst et al., 1987) or
cloned into the pRSET vector with an N-terminal His tag
(Invitrogen Corporation, Carlsbad, CA) under control of an
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IFN-gBPs were constructed by standard PCR mutagenesis
in the vector pTM1-t7ectvifn-cbp+. All plasmid constructs
were sequenced to confirm genotype.
Ectromelia virus IFN-cBP expression in E. coli and
purification
A 500 ml culture of E. coli strain BL21(DE3) carrying
pRSETC-ifn-cbp+ were induced in 1 mM IPTG followed by
5 h incubation. The cells were collected by centrifugation,
the cell pellet was resuspended in 6 M Guanidine–HCl, 0.1
M Na-phosphate, and incubated for 1 h at 20 8C. The lysates
were clarified, and the IFN-gBP was purified by Ni+2-NTA
affinity chromatography following the manufacturer’s
instructions for isolation of denatured protein (QIAGEN
Inc.,Valencia, CA). The protein was eluted in 500 mM
imidazole, 8 M urea, 0.1 M Na-phosphate, 0.01 M Tris–
HCl, pH 6.3. Peak fractions (by SDS-PAGE) were pooled,
precipitated with 7.5 M NH4 acetate and resuspended in
PBS containing 0.2% SDS.
Polyclonal antibody generation
IFN-gBP was purified from a pRSET bacteria expression
system (Invitrogen Corporation, Carlsbad, CA). One ml of 1
mg/ml IFN-gBP solution was mixed with an equal volume
of complete Freund’s adjuvant and 0.1 ml of the emulsified
mixture was injected subcutaneously into 10 sites on the
shaved back and flanks of two white, New Zealand rabbits.
The rabbits were boosted three times in similar fashion
using incomplete Freund’s adjuvant. Two weeks following
the last boost, the rabbits were bled out by heart puncture,
and sera prepared, aliquoted and stored at 70 8C.
IFN-cBP expression and purification
Cultures of BS-C-1 cells were co-infected with VACV-
ifn-gbp+ and VACV-t7 viruses in Opti-MEM-1 (GIBCO
Life Technologies, Gaithersburg, MD). After 36 h post-
infection, the culture supernatants containing the IFN-gBP
were clarified, filtered to remove virus and fractionated with
a salt gradient on a Q-sepharose column. Peak fractions
were pooled and fractionated on a Sephadex 200-gel
filtration column. As estimated by SDS-PAGE and silver
staining, N90% of the preparation migrated with an apparent
molecular weight (MW) of 34.6 kDa. This material was
used as a standard in the described experiments.
Transfection
CV-1 cells in 6-well cluster plates were infected with
VACV-t7 at a multiplicity of infection (m.o.i.) of 10 plaque-
forming units (pfu)/cell for 1 h at 37 8C. The cells were then
transfected with pTM1 (2 Ag, vector control) alone or pTM1
containing WT or mutant ifn-cbp+ genes (2 Ag) usingLipofectAMINE 2000 Reagent in Opti-MEM according to
the manufacturer’s protocol (GIBCO Life Technologies,
Gaithersburg, MD). At 24 h post-transfection, supernatant
was collected, clarified, filtered to remove virus and
cytoplasmic extracts were prepared by scraping cells into
800 Al of 0.5% NP-40 lysis buffer (0.14 M NaCl, 1 mM
MgCl2, 10 mM Tris–HCl [pH 8.5], 0.5% Nonidet-P40 [NP-
40], and 1 mM phenylmethylsulfonyl fluoride). The cell
lysate was clarified by pelleting for 10 min at 21,000 rpm
prior to analysis of the supernatant by SDS-PAGE. IFN-gBP
could not be detectable in the NP-40 insoluble fraction by
Western blot (data not shown).
SDS-PAGE and Western blotting (immunoblotting)
Proteins were separated by discontinuous SDS-PAGE
with a 12% resolving gel prior to electrophoretic transfer
onto nitrocellulose filters (Pall Corp., Ann Arbor, MI).
Molecular weights were estimated using BenchMark molec-
ular weight standards (GIBCO LIFE TECHNOLOGIES,
Gaithersburg, MD). Filters were preincubated for at least 1 h
at room temperature (RT) in PBS-0.1% Tween-5% nonfat
dry milk followed sequentially by a 1-h incubation at RT
with polyclonal rabbit anti-IFN-gBP antibody (1:10,000).
The immunoreactive protein was developed with horse-
radish peroxidase-conjugated goat anti-rabbit IgG (H + L)
(Kirkegaard and Perry Laboratories, Gaithersburg, MD)
using the enhanced chemiluminescence plus (ECL plus)
protein identification system (Amersham Pharmacia Biotech
Inc., Piscataway, NJ) according to the manufacturer’s
instructions. Proteins were quantitated by ImageQuaNTTM
analysis software using a standard curve of purified IFN-
gBP (Molecular Dynamics, Sunnyvale, CA).
Mutagenesis
Single base mutations were carried out using the Gene
Editor site directed mutagenesis system (Promega Corpo-
ration, WI), and a two-step PCR protocol (Kammann
et al., 1989). All mutant ifn-cbp genes contained native
IFN-gBP signal peptide and genotypes were confirmed
by sequencing.
Competitive ELISA
The IFN-gBP was diluted in phosphate buffered saline
(PBS, pH 7.4), and coated at varying concentrations into the
wells of 96 well microtiter plates (Immulon 2 plates, ISC
BioExpress, Kaysville, UT). Following overnight incuba-
tion at 4 8C, the plates were washed and blocked by
incubation with PBS (pH 7.4) containing 0.1% gelatin.
Different concentrations of WT or mutant IFN-gBP and 3.2
ng of biotinylated murine IFN-g were mixed and incubated
at room temperature for 30 min. The tracer and competitor
were then added to a IFN-gBP coated 96-well plate.
Following incubation at RT for 1 h, the plates were washed
H. Bai et al. / Virology 334 (2005) 41–50 49and a 1:5000 dilution of streptavidin-horseradish peroxidase
(Kirkegaad and Perry Laboratories, Gaithersburg, MD) was
added for 0.5 h at RT. Washed wells were then incubated
with O-phenylenediamine dihydrochloride (OPD) substrate
(Sigma, St. Louis, MO) for 15 min. The quantity of bound
murine IFN-g tracer was determined by measurement of
color development at 490 nm in a Biokinetics EL-340
microplate reader. Control wells contained 50 ng of
immobilized gelatin, and the background OD values were
usually less than 0.15.
Glycosidase digestion
Digestion of purified IFN-gBP (2.6 Ag) or the bovine
fetuin control protein (24 Ag) were performed according to
the manufacturer’s instructions with 2 milliunits of O-
Glycanase, 10 milliunits of Sialidase II in 50 mM sodium
phosphate (pH 6.0) at 37 8C for 4 h, and/or denatured
samples were treated with 5 milliunits of N-Glycanase (N-
glycosidase F) in 0.5 M Na2HPO4 (pH 7.5) at 37 8C for 3 h.
For endoglycosidase H (Endo H) digestion, samples of
immunoprecipitates were boiled for 5 min in 40 Al of H2O
containing 0.2% SDS, 1% 2-mercaptoethanol. Denatured
samples were divided into two equal aliquots and treated
with buffer (100 mM sodium citrate, pH 5.5) alone and/or
Endo H at a final concentration of 30 milliunits per ml for
20 h at 37 8C.
Pulse-chase experiments and immunoprecipitation
BS-C-1 cells in 6 well cluster plate were infected with
ECTV at m.o.i of 20 pfu/cell and incubated in complete
media at 37 8C for 4 h.p.i. Media was removed and the
cultures were incubated for 20 min in Met/Cys-free
DMEM, labeled with [35S]-L-Met/Cys (200 ACi/ml) for
15 min, and followed by a chase with Opti-MEM. When
infected cells were incubated with tunicamycin (5 Ag/ml),
the drug was added to cultures 1 h prior to, and maintained
throughout, the [35S]-L-Met/Cys labeling period. Culture
supernatants and cell lysates were harvested at indicated
time points. Immunoprecipitations were carried out over-
night at 4 8C using anti-IFN-gBP polyclonal antibody
immobilized onto protein G-agarose beads (Roche Diag-
nostics Corporation, Indianapolis, IN). The beads were
washed three times with immunoprecipitation buffer (20
mM NaH2PO4 d H2O, 250 mM NaCl , 30 mM
Na4P2O7d 10H2O, 10 mM NaF, 5 mM EDTA, 0.1% NP-
40, pH 7.0). Precipitates were analyzed by 12% SDS-PAGE
and visualized by fluorography.
Surface plasmon resonance (Biacore)
Real-time interaction of IFN-gBP with murine IFN-g was
measured by SPR on a Biacore 2000 (Biacore Inc., Piscat-
away, NJ). Flow cells of a CM5 (carboxymethylated dextran)
sensor chip were activated using 50 mM N-hydroxysucci-nimide and 200 mM N-ethyl-NV-(dimethylaminopropyl)car-
bodiimide for 6 min at a flow rate of 5 Al/min. Murine IFN-g
(R&D Systems, Minneapolis, MN) diluted in 10 mM sodium
acetate pH 5.0, was immobilized at a flow rate of 5 Al/min for
5 min. The surface was treated using 1 M ethanolamine
hydrochloride at pH 8.5 for 7 min with a flow rate of 5 Al/min
to deactivate excess reactive esters and remove non-
covalently bound ligand. The murine IFN-g surface was
stable following repeated rounds of regeneration and was
stable for several weeks. The IFN-gBP samples were
injected in random order at concentrations ranging from
100 to 1 nM diluted in HBS-EP running buffer (10 mM
HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, .005%
Surfactant P20, Biacore, Inc.). To correct for refractive index
changes, responses generated with the control (activated and
blocked) surface were subtracted from the responses with the
murine IFN-g surface. Data were analyzed and fit globally to
the 1:1 binding model using BIAevaluation 3.2 software.Acknowledgments
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